PTAB

IPR2020-00040

Mylan Pharmaceuticals, Inc. v. Merck Sharp & Dohme Corp.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

10/30/19

Institution05/12/20

FWD05/07/21

Close05/07/21

StatusFinal Written Decision

OutcomePatentable

Appeals

Administrative Patent Judges

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Roberta Pollock	500+	50%	50%
Timothy G Majors	500+	50%	50%
Sheridan K Snedden	500+	50%	50%

Petitioner

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A

No Parties

Attorney

Name	Ratings
Lerner David Littenberg Krumholz & Mentlik LLP	L5 A
Patrick J. Coyne	L5 A
Peter Kinsella	L5 A
Hugh S. Balsam	L5 A
Goodwin Procter LLP	L5 A
Neal S. Cohen	L5 A
Katten Muchin Rosenman LLP	L5 A
Scott E. Holwick	L5 A
Scott J. Popma	L5 A
Jennifer S. Swan	L5 A
Aaron M. Raphael	L5 A
Winston & Strawn LLP	L5 A
Robert D. Bajefsky	L5 A

No Attorneys

Respondent

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Merck Sharp & Dohme Corp	L4 A

No Parties

Attorney

No Attorneys